Related Experiment Videos
Low-dose interleukin-2 in the treatment of metastatic renal-cell carcinoma
1Department of Medicine, University of Chicago, IL 60637.
Seminars in Oncology
|February 1, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Ten-year survival rates by PSA nadir in patients with metastatic hormone-sensitive prostate cancer: long-term survival analysis from the ECOG-ACRIN 3805 (CHAARTED) trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
A multicenter, open-label, randomized, phase II study of cediranib with or without lenalidomide in iodine 131-refractory differentiated thyroid cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2023
Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology·2022
Antitumor activity of ipatasertib combined with chemotherapy: results from a phase Ib study in solid tumors.
Annals of oncology : official journal of the European Society for Medical Oncology·2020
Bone turnover biomarkers identify unique prognostic risk groups in men with castration resistant prostate cancer and skeletal metastases: Results from SWOG S0421.
Cancer treatment and research communications·2019
Bone metastasis in cancer: from microenvironmental remodeling to precision therapy.
Seminars in oncology·2026
Rhabdomyolysis resulting from the interaction of rosuvastatin and abiraterone: A case study.
Seminars in oncology·2026
NK3 subsets are linked to NK cell exhaustion and immunotherapy responsiveness in tumor.
Seminars in oncology·2026
Timing of cranial radiotherapy in HER2-positive breast Cancer brain metastases treated with Pyrotinib: a multicentre real-world cohort study.
Clinical and translational radiation oncology·2026
A HALF CENTURY OF PROGRESS IN BREAST CANCER: WHERE DO WE GO NEXT?
Transactions of the American Clinical and Climatological Association·2026
Engineering exosomes-mediated RNA delivery regulates bone homeostasis and alleviates osteoporosis.
Materials today. Bio·2026